USA Financial Formulas
VRTX icon

USA Financial Formulas’s Vertex Pharmaceuticals VRTX Stock Holding History

USA Financial Formulas’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.12M Buy
+2,134
New +$1.09M 0.22% 29
2024
Q3 		– Sell
-2,115
Closed -$991K – 368
2024
Q2 		$991K Sell
2,115
-2,046
-49% -$888K 0.16% 71
2024
Q1 		$1.74M Sell
4,161
-2,279
-35% -$963K 0.28% 22
2023
Q4 		$2.62M Sell
6,440
-1,224
-16% -$452K 0.46% 16
2023
Q3 		$2.67M Sell
7,664
-2,170
-22% -$759K 3.98% 1
2023
Q2 		$3.46M Sell
9,834
-780
-7% -$263K 5.32% 1
2023
Q1 		$3.34M Buy
+10,614
New +$3.18M 5.42% 3
2022
Q3 		$3.85M Sell
13,295
-792
-6% -$228K 6.07% 1
2022
Q2 		$3.97M Buy
+14,087
New +$3.77M 4.96% 1
2022
Q1 		– Sell
-13
Closed -$3K – 495
2021
Q4 		$3K Hold
13
– – ﹤0.01% 247
2021
Q3 		$2K Hold
13
– – ﹤0.01% 331
2021
Q2 		$3K Buy
13
+3
+30% +$628 ﹤0.01% 288
2021
Q1 		$2K Buy
10
+1
+11% +$220 ﹤0.01% 280
2020
Q4 		$2K Sell
9
-9,067
-100% -$2.08M ﹤0.01% 242
2020
Q3 		$2.47M Sell
9,076
-6,289
-41% -$1.74M 1.86% 16
2020
Q2 		$4.46M Buy
15,365
+696
+5% +$189K 3.32% 8
2020
Q1 		$3.49M Buy
+14,669
New +$3.36M 2.22% 9
2019
Q1 		– Sell
-40,700
Closed -$7.84M – 353
2018
Q4 		$7.84M Buy
+40,700
New +$7.05M 1.95% 16
2017
Q4 		– Sell
-39,969
Closed -$6.08M – 344
2017
Q3 		$6.08M Buy
39,969
+17,099
+75% +$2.57M 1.45% 12
2017
Q2 		$2.95M Buy
+22,870
New +$2.75M 0.71% 58

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
AMF Tjänstepension
AMF Tjänstepension Stockholm, Sweden $17.2B AUM 28.3% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $57B AUM 43.56% 1-Year Est. Return
Davenport & Co
Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

USA Financial Formulas's VRTX Position: Q3 2026 in Review

USA Financial Formulas opened a new position in Vertex Pharmaceuticals (VRTX) in Q3 2026: 2,134 shares worth $1.12M. The stake represents 0.22% of the portfolio and ranks #29 among its holdings. This is a return to the name: USA Financial Formulas previously reported a position in VRTX as recently as Q2 2024.

USA Financial Formulas first reported a position in VRTX in Q2 2017 and has held it in 20 quarters since. The position peaked at $7.84M in Q4 2018. 637 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • USA Financial Formulas held 2,134 shares of Vertex Pharmaceuticals worth $1.12M as of Q3 2026.
  • Vertex Pharmaceuticals was a new USA Financial Formulas position in Q3 2026.
  • Vertex Pharmaceuticals made up 0.22% of USA Financial Formulas's portfolio in Q3 2026, its #29 holding.
  • USA Financial Formulas first reported a position in Vertex Pharmaceuticals in Q2 2017 and has held it in 20 quarters since.
  • USA Financial Formulas's Vertex Pharmaceuticals position peaked at $7.84M in Q4 2018.
  • 637 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on USA Financial Formulas's 13F filing for Q3 2026, filed 16 Oct 2026.